DCM
IRMD icon

Davidson Capital Management’s iRadimed IRMD Stock Holding History

Davidson Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.42M Buy
56,684
+1,662
+3% +$151K 0.87% 31
2026
Q1 		$5.3M Buy
55,022
+54,895
+43,224% +$5.49M 0.96% 28
2025
Q4 		$12.4K Buy
+127
New +$10.9K ﹤0.01% 72

Other funds holding IRMD

SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
ADMI
Albert D. Mason Inc Boston, Massachusetts $176M AUM 40.3% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Davidson Capital Management's IRMD Position: Q2 2026 in Review

Davidson Capital Management increased its iRadimed (IRMD) stake by 3% in Q2 2026, buying an estimated $151K and bringing the position to 56,684 shares worth $5.42M. The position accounts for 0.87% of the portfolio, ranked #31.

Davidson Capital Management first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. 44 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Davidson Capital Management held 56,684 shares of iRadimed worth $5.42M as of Q2 2026.
  • Davidson Capital Management bought 1,662 iRadimed shares in Q2 2026, an estimated $151K.
  • iRadimed made up 0.87% of Davidson Capital Management's portfolio in Q2 2026, its #31 holding.
  • Davidson Capital Management first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • 44 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Davidson Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.